NCT06238258

Brief Summary

This is a clinical trial, with participants undergoing the 16 hour SPECTROM training, and completing 2 assessments before and after training (the Psychotropic Knowledge Questionnaire-Revised and the Management of Aggression and Violence Attitude Scale-Revised-ID).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

1.3 years

First QC Date

January 25, 2024

Last Update Submit

March 20, 2026

Conditions

Training Group

Keywords

intellectual disability

Outcome Measures

Primary Outcomes (1)

  • Knowledge Acquisition Post Training

    Completion of assessments

    6 months

Study Arms (1)

Training Arm

EXPERIMENTAL
Behavioral: SPECTROM Training

Interventions

SPECTROM TrainingBEHAVIORAL

Training regarding treatment of behavioral challenges in adults with intellectual disability

Training Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • All participants must be fluent in English because for this pilot study we do not have funds to translate study materials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNM Health Science Center

Albuquerque, New Mexico, 87106, United States

Location

MeSH Terms

Conditions

Intellectual Disability

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Emeritus

Study Record Dates

First Submitted

January 25, 2024

First Posted

February 2, 2024

Study Start

July 1, 2024

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

March 25, 2026

Record last verified: 2026-03

Locations

US(1)